FDA Approved: NEXIUM 24HR CLEARMINIS — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

FDA approved a supplemental application for NEXIUM 24HR CLEARMINIS (esomeprazole magnesium) filed by Haleon US Holdings LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Helicobacter Pylori Infection
• Nsaid-induced Gastroduodenal Ulcers
• Zollinger-ellison Syndrome

Drugs mentioned

• NEXIUM 24HR CLEARMINIS (Esomeprazole magnesium)

Snippet

SUPPL AP for NEXIUM 24HR CLEARMINIS (ESOMEPRAZOLE MAGNESIUM)